Most of the tainted drugs originated in India and China, which have become popular sources of generic medications and active-drug ingredients as producers and health-care providers try to hold down costs.
Sun Pharmaceutical is scouting for a partner in China to help it win a larger piece of the world’s second-largest drug market, where the government is on a mission to drive down the cost of healthcare.
The U.S.’s biggest pharmaceutical companies are beginning to prepare for a new and potentially challenging chapter after reaping the rewards of a fruitful period of cancer research.
Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens.
Pharma companies ramped up their stockpiles of drugs to prepare for a potentially chaotic Brexit. Now they’re in the dark about how long they’ll need to hold them.
President Xi Jinping’s drive to turn China into a biomedical powerhouse has pushed the country deeper into drug discovery and to the forefront of genetics.
When Huawei announced its latest smartphone last week, the world’s largest telecommunications gear maker also shared another product. Track AI promises to pair software with Huawei devices to let “non-trained professionals” diagnose eye conditions.
For more than two years, the clock ran down toward March 29, the day Prime Minister May pledged Britain would leave the European Union. As the drama rolls on, the costs mount from the Brexit day that wasn’t.
Effective emergency response to a natural disaster requires rapid, coordinated action among multiple parties. Suffice to say that such a level of efficiency has been sadly lacking in many prior relief efforts. Can blockchain make it happen?
RSS
